Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $-1.78M in the quarter ending September 30, 2024, a decrease of -161.06%. This brings the company's revenue in the last twelve months to $9.21M, up 187.45% year-over-year. In the year 2023, Verrica Pharmaceuticals had annual revenue of $5.12M, down -43.27%.

• Revenue (ttm): $9.21M
• Revenue Growth: +187.45%
• P/S Ratio: 4.48
• Revenue / Employee: $92,100
• Employees: 100
• Market Cap: 43.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.